20/20 Biolabs Inc. (AIDX) vs Basel Medical Group Ltd Ordinary Shares (BMGL)

A side-by-side comparison of 20/20 Biolabs Inc. and Basel Medical Group Ltd Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
20/20 Biolabs Inc. logo
AIDX
20/20 Biolabs Inc.
$4M
$0.35HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
Basel Medical Group Ltd Ordinary Shares logo
BMGL
Basel Medical Group Ltd Ordinary Shares
$5M
$3.36HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT

Total return — AIDX vs BMGL

growth of $100 · dividends reinvested · last 1y
AIDX -98.5% (-98.5%/yr)BMGL -61.2% (-61.2%/yr)BMGL compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100$1$39
AIDX BMGL

AIDX vs BMGL: by the numbers

  • •BMGL is the larger company ($5M vs $4M market cap).
  • •Both run net losses; BMGL's is the smaller (-106.78% vs -285.00% net margin).

Metrics side by side

Valuation

MetricAIDXBMGL
P/S ratio2.10N/A
P/B ratio2.651.08

Profitability

MetricAIDXBMGL
Gross margin31.52%77.68%
Operating margin-162.87%-19.28%
Net margin-285.00%-106.78%
ROE-184.04%-248.66%
ROIC-116.89%-35.07%

Growth (annualized)

MetricAIDXBMGL
Revenue CAGR (5Y)-2.58%N/A

Go deeper

Full AIDX analysisFull BMGL analysisInteractive comparison tool

Dig into the metrics

20/20 Biolabs ROEBasel Medical Group Ltd Ordinary Shares ROE20/20 Biolabs operating marginBasel Medical Group Ltd Ordinary Shares operating margin20/20 Biolabs revenue growthBasel Medical Group Ltd Ordinary Shares revenue growth20/20 Biolabs free cash flowBasel Medical Group Ltd Ordinary Shares free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.